Cargando…
Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial
AIMS: Venoarterial extracorporeal membrane oxygenation (VA‐ECMO) is increasingly being used in circulatory failure. The main indications are cardiogenic shock, post‐cardiotomy cardiac failure, and refractory cardiac arrest. However, VA‐ECMO weaning is particularly challenging, and weaning failure is...
Autores principales: | Ellouze, Omar, Soudry Faure, Agnès, Radhouani, Mohamed, Abou‐Arab, Osama, Besnier, Emmanuel, Moussa, Mouhamed, Cransac, Amélie, Ksiazek, Elea, Fischer, Marc‐Olivier, Mertes, Paul Michel, Bouhemad, Belaid, Guinot, Pierre Grégoire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318420/ https://www.ncbi.nlm.nih.gov/pubmed/34145993 http://dx.doi.org/10.1002/ehf2.13427 |
Ejemplares similares
-
Levosimendan for VA‐ECMO weaning: the silver lining
por: Kaddoura, Rasha, et al.
Publicado: (2021) -
How I approach weaning from venoarterial ECMO
por: Fried, Justin A., et al.
Publicado: (2020) -
Echocardiographic measure of dynamic arterial elastance predict pressure response during norepinephrine weaning: an observational study
por: Nguyen, Maxime, et al.
Publicado: (2021) -
A single dose of tramadol in continuous wound analgesia with levobupivacaine does not reduce post-sternotomy pain: a randomized controlled trial
por: Bethenod, Floriane, et al.
Publicado: (2019) -
Impact of levosimendan on weaning from peripheral venoarterial extracorporeal membrane oxygenation in intensive care unit
por: Vally, Shamir, et al.
Publicado: (2019)